Research shows that people using GLP-1 therapy can unintentionally eat too little protein, fiber, or micronutrients (like calcium, magnesium, and vitamins A, D, E, and K) as appetite and total food intake decrease
ArticlePubMedPMC 170
How PlexusDx Supports a More Personalized Approach PlexusDx recommends baseline biomarker assessmentfasting lipids, glucose, inflammatory markers (hs-CRP if available), and liver/kidney functionbefore initiating any GLP-1 compound
This gradual improvement is due to the medications cumulative effect as it builds up in the system
SeekPeptides members have been asking these questions for months, and the answers are more interesting than you might expect
We believe that one of the important mechanisms underlying this effect is likely reduction of inflammation in the fatty tissue around the heart, which we know is an important driver of arrhythmias and other unwanted cardiac outcomes. Bilchick plans to continue investigating these inflammatory mechanisms in collaboration with UVA immunology researcher Coleen McNamara, UVA MRI physicist Frederick Epstein (who developed an MRI method to characterize fatty tissue surrounding the heart), and UVA Director of Cardiac Imaging Amit Patel
